نتائج البحث

Mutation of neurotrophic tyrosine receptor kinase can promote pan-cancer immunity and the efficacy of immunotherapy

• Authors : Congren Wang; Yingying Li; Jinyuan Huang

Subjects: Neurotrophic tyrosine receptor kinase; Immunotherapy; Cancer

• Source: Molecular Cancer, Vol 23, Iss 1, Pp 1-5 (2024)

تفاصيل العنوان

Enhancing therapeutic anti-cancer responses by combining immune checkpoint and tyrosine kinase inhibition.

• Authors : Daly RJ; Cancer Program, Monash Biomedicine Discovery Institute, Monash University, 23 Innovation Walk, Clayton, VIC, 3800, Australia. .; Department of Biochemistry & Molecular Biology, Monash University, 23 Innovation Walk, Clayton, VIC, 3800, Australia. .

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/therapy ; Protein-Tyrosine Kinases*; Humans

• Source: Molecular cancer [Mol Cancer] 2022 Sep 29; Vol. 21 (1), pp. 189. Date of Electronic Publication: 2022 Sep 29.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes.

• Authors : Dalens, Lorraine¹ (AUTHOR); Niogret, Julie¹ (AUTHOR); Richard, Corentin² (AUTHOR)

• Source: Molecular Cancer. 7/29/2023, Vol. 22 Issue 1, p1-9. 9p.

تفاصيل العنوان

Mutation of neurotrophic tyrosine receptor kinase can promote pan-cancer immunity and the efficacy of immunotherapy.

• Authors : Wang, Congren¹ (AUTHOR); Li, Yingying^1,2 (AUTHOR); Huang, Jinyuan^1,2 (AUTHOR)

• Source: Molecular Cancer. 4/25/2024, Vol. 23 Issue 1, p1-5. 5p.

تفاصيل العنوان

Novel humanized monoclonal antibodies against ROR1 for cancer therapy.

• Authors : Wei R; Laboratory of Molecular Oncology, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China.; Liao X

Subjects: Receptor Tyrosine Kinase-like Orphan Receptors*/Receptor Tyrosine Kinase-like Orphan Receptors*/Receptor Tyrosine Kinase-like Orphan Receptors*/metabolism ; Receptor Tyrosine Kinase-like Orphan Receptors*/Receptor Tyrosine Kinase-like Orphan Receptors*/Receptor Tyrosine Kinase-like Orphan Receptors*/antagonists & inhibitors ; Receptor Tyrosine Kinase-like Orphan Receptors*/Receptor Tyrosine Kinase-like Orphan Receptors*/Receptor Tyrosine Kinase-like Orphan Receptors*/immunology

• Source: Molecular cancer [Mol Cancer] 2024 Aug 13; Vol. 23 (1), pp. 165. Date of Electronic Publication: 2024 Aug 13.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

Identification of lymphocyte cell-specific protein-tyrosine kinase (LCK) as a driver for invasion and migration of oral cancer by tumor heterogeneity exploitation.

• Authors : Weiße, Jonas¹ (AUTHOR); Rosemann, Julia¹ (AUTHOR); Müller, Lisa² (AUTHOR)

• Source: Molecular Cancer. 6/11/2021, Vol. 20 Issue 1, p1-23. 23p.

تفاصيل العنوان

Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes

• Authors : Lorraine Dalens; Julie Niogret; Corentin Richard

Subjects: Lung carcinoma; Exome analysis; SNPs

• Source: Molecular Cancer, Vol 22, Iss 1, Pp 1-9 (2023)

تفاصيل العنوان

AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications.

• Authors : Zhu C; Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No. 17, Block 3, Southern Renmin Road, Chengdu, Sichuan, 610041, People's Republic of China.; Department of Radiation Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, 42 Baiziting, Nanjing, 210009, Jiangsu, China.

Subjects: Biomarkers, Tumor*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Neoplasms/Neoplasms/Neoplasms/*etiology

• Source: Molecular cancer [Mol Cancer] 2019 Nov 04; Vol. 18 (1), pp. 153. Date of Electronic Publication: 2019 Nov 04.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

Enhancing therapeutic anti-cancer responses by combining immune checkpoint and tyrosine kinase inhibition

• Authors : Roger J. Daly; Andrew M. Scott; Oliver Klein

Subjects: Immuno-oncology; Tumor microenvironment; Targeted therapy

• Source: Molecular Cancer, Vol 21, Iss 1, Pp 1-20 (2022)

تفاصيل العنوان

EYA4 promotes breast cancer progression and metastasis through its role in replication stress avoidance.

• Authors : de la Peña Avalos, Bárbara^1,2,3,4 (AUTHOR); Tropée, Romain^1,5 (AUTHOR); Duijf, Pascal H. G.^1,6,7,8 (AUTHOR)

• Source: Molecular Cancer. 9/30/2023, Vol. 22 Issue 1, p1-18. 18p.

تفاصيل العنوان